Sivasubramanian Baskar

Author

Center for Cancer Research ORCID

Also Known As

A Morgan, S Baskar, S. Baskar, S. Saravana Baskar, SJK Abraham, Sivasubramanian Baskar, T Sheeran

210

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Center for Cancer Research National Institutes of Health National Cancer Institute National Heart Lung and Blood Institute Science Applications International Corporation (United States)

About

Sivasubramanian Baskar is an author at Center for Cancer Research specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	708
2	Cell Biology	4	4	508
3	Engineering	1	1	11
4	Allergy	1	1	13
5	Biomedical Engineering	1	1	11

Sivasubramanian Baskar

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Sivasubramanian Baskar, Suzanne Ostrand‐Rosenberg, N Nabavi, Proceedings of the National Academy of Sciences HistocompatibilityResident Tumor CellsT-regulatory CellImmunologyImmunologic Mechanism	1993	268
The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor Michael Hudecek, Thomas M. Schmitt, Sivasubramanian Baskar, Blood	2010	264
Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia Sivasubramanian Baskar, Ka Yin Kwong, Thomas Höfer, Clinical Cancer Research	2008	240
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease Davide Bagnara, Matthew Kaufman, Carlo Calissano, Blood	2011	217
Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. Sivasubramanian Baskar, Laurie H. Glimcher, N Nabavi, The Journal of Experimental Medicine HistocompatibilityClass IiImmunologyPotent VaccinesImmunotherapy	1995	185
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era Hannah R. Robinson, Junpeng Qi, Erika M. Cook, Blood	2018	106
Fish Oil and Tocopherol-Induced Changes in Natural Killer Cell-Mediated Cytotoxicity and PGE2 Synthesis in Young and Old Mice Simin Nikbin Meydani, Ganesa Yogeeswaran, Sandra Liu, Journal of Nutrition InflammationCytokineOld MicePge2 SynthesisImmunotoxicology	1988	103
Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies Jiahui Yang, Sivasubramanian Baskar, Ka Yin Kwong, PLoS ONE	2011	97
Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen Sattva S. Neelapu, Sivasubramanian Baskar, Barry L. Gause, Clinical Cancer Research	2004	74
Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules Sivasubramanian Baskar, Virginia K. Clements, L H Glimcher, The Journal of Immunology	1996	71

Page 1